The high rates of morbidity and mortality caused by fungal infections are associated with the
current limited antifungal arsenal and the high toxicity of the compounds. Additionally …

Abstract Approximately 70‐75% of women will have vulvovaginal candidosis (VVC) at least
once in their lifetime. In premenopausal, pregnant, asymptomatic and healthy women and …

The Candida genus comprises opportunistic fungi that can become pathogenic when the
immune system of the host fails. Candida albicans is the most important and prevalent …

The genus Candida includes about 200 different species, but only a few species are human
opportunistic pathogens and cause infections when the host becomes debilitated or …

Despite improvement of antifungal therapies over the last 30 years, the phenomenon of
antifungal resistance is still of major concern in clinical practice. In the last 10 years the …

Non-albicans Candida (NAC) species cause 35–65% of all candidaemias in the general
patient population. They occur more frequently in cancer patients, mainly in those with …

Candida albicans and related species pathogenic for man become resistant to antifungal
agents, in particular triazole compounds, by expression of efflux pumps that reduce drug …

The frequency of invasive mycoses due to opportunistic fungal pathogens has increased
significantly over the past two decades (35, 74, 83, 88, 89, 101, 106). This increase in …

Presenting state-of-the-art research advancements, this volume explores innovative
approaches to effectively apply existing porous media technologies to biomedical …

The significant increase in the use of antifungal agents, both for the treatment of candidiasis
and invasive aspergillosis and as azole fungicides in agricultural crop protection has …